Drug profile

The FDA adverse-event record for Gonadorelin Diacetate Tetrahydrate

158 adverse-event reports submitted to the FDA Center for Veterinary Medicine reference Gonadorelin Diacetate Tetrahydrate. See the species affected, top reactions, and outcomes below.

158
adverse-event reports
0.6%
death-coded share
Unknown
most-reported species
54
Vials, Damaged - top reaction
Verify with FDA CVM →
Important: Adverse event reports do not establish that a drug caused or contributed to the event. Consult your veterinarian before making treatment decisions.
158
Total Reports
1
Deaths Reported
0.6%
Death Rate

Active Ingredients

Gonadorelin Diacetate Tetrahydrate

Administration Routes

UnknownIntramuscularTopicalParenteralSubcutaneous

Species Affected

Unknown 112
Cattle 38
Human 8

Most Affected Breeds

Unknown 120
Mixed (Cattle) 11
Aberdeen Angus 10
Cattle (other) 9
Cattle (unknown) 4
Brangus 1
Hereford cattle 1
Red Angus 1
Holstein-Friesian also known as Holstein 1

Most Reported Reactions

Vials, Damaged 54
Lack of efficacy - NOS 19
Seal, Abnormal 18
INEFFECTIVE, ESTRUS SYNCHRONIZ 16
Unclassifiable adverse event 11
Containers, Damaged 11
Underfilling, Vials 8
Containers, Abnormal 8
Accidental exposure 7
Closure, Abnormal 7
Physical label missing 5
Vials, Leaking 5

Outcome Breakdown

Outcome Unknown
32 (91.4%)
Recovered/Normal
2 (5.7%)
Died
1 (2.9%)

Gonadorelin Diacetate Tetrahydrate Adverse Event Insights

158 reports name Gonadorelin Diacetate Tetrahydrate; 1 recorded a death outcome (0.6% of reported events, not a population-level mortality rate). Active ingredient: Gonadorelin Diacetate Tetrahydrate. Administration routes: Unknown, Intramuscular, Topical, Parenteral.

By species: Unknown (112 reports), Cattle (38 reports), Human (8 reports). By breed: Unknown (120), Mixed (Cattle) (11), Aberdeen Angus (10).

Leading clinical signs: Vials, Damaged (54), Lack of efficacy - NOS (19), Seal, Abnormal (18), INEFFECTIVE, ESTRUS SYNCHRONIZ (16). Outcome, 35 coded reports: Outcome Unknown leads at 91.4%.

Read these counts as reporting volume, not risk: per our methodology, a widely-prescribed drug will rack up more raw FDA reports in a given year than a rarely-used one at an identical true rate, so we recommend comparing within similar-exposure products rather than across the full 2025 catalog.

Source: FDA Center for Veterinary Medicine openFDA Animal & Veterinary Adverse Events (CVM AER) · 2025

Every figure on PlainBreed is rendered directly from FDA openFDA adverse event data, no number is typed in by an editor. This page draws directly on FDA openFDA data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.